Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: American Spirit who wrote (498325)	11/25/2003 11:32:06 AM
From: willcousa	Read Replies (1) \| Respond to of 769670

It will never work if we stop working on it. What if we do develop offensive weapons from the effort?

To: American Spirit who wrote (498325)	11/25/2003 1:28:33 PM
From: Tech Master	Respond to of 769670

I am familiar with substantial medical technologies that came out of the SDI program. While you claim that SDI is a boondoggle, some MIT developed SDI technology is currently being used on the forefront of cancer treatment with enormously successful results. If we fail at shooting down missiles from space but develop highly effective, non-toxic and non-invasive cancer treatments.... was it worth it? Damn skippy.

To: American Spirit who wrote (498325)	11/26/2003 3:30:38 PM
From: Tech Master	Read Replies (1) \| Respond to of 769670

AS: OT: I'll throw you a bone for Thanksgiving because I'm in a holiday mood. As I mentioned, there is a company that is using some SDI microwave technologies to treat cancer. The company is Celsion Corporation (AMEX:CLN) and they will be presenting during the American Stock Exchange investor conference next week. You can listen to the presentation here: firstcallevents.com The technology portfolio is amazing. The breast cancer trials that focus heat only on the tumors and jam the microwaves where the healthy tissue is is right out of the Star Wars program. CLN is also developing heat sensitive liposomes that deliver chemotherapy only to the tumor in doses 30-50X compared to traditional systemic delivery. Next-generation Benign Prostate Hypertrophy (BPH) treatment is ready for final FDA approval, the National Institute of Health is getting ready to use liposomes for liver cancer trials, and prostate cancer trials using heat and liposomes underway. IMO CLN is a promising biotechnology star moving forward. Boston Scientific teamed up with them to market the BPH treatment. Happy holidays.... and just maybe you can benefit as your tax dollars spent on Star Wars will actually help save lives. Republicans saving lives :)